DigniCap offers patients the ability to reduce hair loss from certain chemotherapy treatments and is FDA cleared for patients with solid tumors.

Scalp cooling is a proven approach to reduce chemotherapy-induced alopecia that has been used successfully by thousands of patients worldwide for decades. Reduced temperature results in a decreased blood flow to the scalp area so that less chemotherapy reaches the hair cells. Therefore, hair cells are not exposed to the full dose of chemotherapy and may be able to survive the chemotherapy treatment.

The DigniCap Scalp Cooling System consists of a computerized cooling unit managed through a touch screen display and an attached cooling cap. Temperature regulated coolant continuously circulates though specially designed channels in the cooling cap. The ability to maintain continuous, direct contact between the cooling cap and scalp for a consistent treatment temperature is a key factor in the effectiveness of DigniCap.

Made in USA.